Heidelberg, Germany

Jens-Christian Wunderlich

This inventor holds 16 USPTO granted patents. Top assignees: Alfatec-Pharma Gmbh, Paz Arzneimittelentwicklungsgesellschaft Mbh, Alfatec-Pharm Gmbh. Active years: 1993-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jens-Christian Wunderlich. Retrieved from https://idiyas.com/inventor/jens-christian-wunderlich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 12

Forward Citations = 342(Granted Patents)


Company Filing History:


Years Active: 1993-2002

Loading Chart...
16 patents (USPTO):Explore Patents

Title: **Jens-Christian Wunderlich: Innovator in Pharmaceutical Deliveries**

Introduction

Jens-Christian Wunderlich is a prominent inventor based in Heidelberg, Germany. With an impressive portfolio of 16 patents, he has made significant contributions to the field of pharmaceuticals, particularly in the area of peptide-based medications.

Latest Patents

Wunderlich's most recent patents showcase his innovative approaches to improving the efficacy and delivery of peptide pharmaceuticals. One notable invention is a **peroral dosage form for peptide containing medicaments**, specifically insulin. This dosage form employs a matrix of gelatin or gelatin derivatives, ensuring that the peptide pharmaceutical is distributed effectively while protecting it from enzymatic degradation by peptidases in the digestive tract.

Another significant patent involves **solid bodies containing active substances** where accurately metered shaped articles, such as granules or pellets, are developed. These articles contain hydrophilic macromolecules and active compounds, produced through a novel process that is both cost-effective and environmentally friendly. The shaped articles not only enhance bioavailability, shelf life, and tolerability but also serve multiple purposes across pharmacy, cosmetics, diagnostics, and dietetics.

Career Highlights

Throughout his career, Jens-Christian Wunderlich has had the opportunity to work with reputable companies such as Alfatec-Pharma GmbH and Paz Arzneimittelentwicklungsgesellschaft Mbh. His expertise has played a crucial role in advancing the development of innovative drug formulations.

Collaborations

Wunderlich has collaborated with various talented professionals in his field, including Ursula Schick and Jurgen Werry. Together, they contributed to groundbreaking research and development in pharmaceutical sciences, furthering the potential for improved healthcare solutions.

Conclusion

Jens-Christian Wunderlich continues to pave the way for advancements in medication delivery systems. His inventive mind is dedicated to enhancing the effectiveness of peptide-based therapeutics, which plays a vital role in modern medicine. As innovations in this field continue to evolve, Wunderlich’s contributions remain noteworthy in shaping the future of pharmaceutical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…